Sumayang, Nolasco L.

HRN: 24-37-97  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2024
CEFTRIAXONE 1G (VIAL)
01/14/2024
01/21/2024
IV
2g
Q24
Cellulitis Left Leg; R/O PAOD
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: